Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
HuidaGene Appoints New Members to the Scientific Advisory Board
HuidaGene Therapeutics (辉大基因; HuidaGene), a global clinical-stage biotechnology company focused on developing genomic medicine, has […]
Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board
Immunome, a clinical-stage biopharmaceutical company that discovers novel target-antibody pairs through its unbiased interrogation of […]
Vivera Welcomes CPG Leader Karen Antonio to its Advisory Board
Direct-to-consumer, consumer packaged goods (CPG), business development, and retail distribution expert Karen Antonio has joined Vivera […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more